Healthcare Trust of America, Inc. HTA
Set alert
29.19 0.00 0.00%
At close
28.78 Day range 29.71
52-week range unavailable
- Open
- 29.21
- Prev close
- 29.19
- Mkt cap
- 11.11B
- Vol
- 64.62M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 3.44%
More statistics
- Low
- 28.78
- High
- 29.71
- Forward P/E
- 66.34
- Beta
- 0.63
- Short ratio
- 2.04
- Inst. own
- 98.88%
- Dividend
- 1.00
- Ex-div date
- Jul 17, 2022
- Earnings
- Aug 2, 2022
- 50-d avg
- 28.84
- 200-d avg
- 31.36
- 1y target
- 33.06
Analyst view
Consensus: hold
Hold
Price target (mean) 33.06 +13.3% upside
Now 29.19
- Target (low)
- 28.00
- Target (mean)
- 33.06
- Target (high)
- 36.50
Ratings (0m) 12 9 buy · 3 hold · 0 sell
- Strong buy5
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 10
- 2 months ago 10
- 3 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09 | 0.09 – 0.09 | 0.17 | -47.1% | 200.46M | 0.0% | 1 |
| Next quarter | 0.10 | 0.10 – 0.10 | 0.10 | 0.0% | 203.03M | +6.0% | 1 |
| Current year | 0.39 | 0.37 – 0.42 | 0.44 | -11.4% | 811.04M | +5.7% | 2 |
| Next year | 0.44 | 0.38 – 0.52 | 0.39 | +12.8% | 833.29M | +2.7% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 10, 2022 | Berenberg | Upgrade | Hold | Buy |
| Feb 1, 2022 | Credit Suisse | Initiated | — | Outperform |
| Nov 24, 2021 | Berenberg | Downgrade | Buy | Hold |
| Sep 30, 2021 | Truist Securities | Downgrade | Buy | Hold |
| Aug 20, 2021 | Raymond James | Downgrade | Outperform | Market Perform |
| Aug 4, 2021 | BMO Capital | Downgrade | Outperform | Market Perform |
| Apr 8, 2021 | SMBC Nikko | Downgrade | Outperform | Neutral |
| Mar 15, 2021 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 28, 2021 | ScotiaBank | Initiated | — | Sector Perform |
| Dec 21, 2020 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 31, 2020 | Raymond James | Upgrade | Market Perform | Outperform |
| Apr 23, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Apr 7, 2020 | Citigroup | Maintained | — | Neutral |
| Apr 3, 2020 | JP Morgan | Maintained | — | Overweight |
| Apr 3, 2020 | Wells Fargo | Maintained | — | Overweight |
| Mar 26, 2020 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 3, 2020 | JP Morgan | Maintained | — | Overweight |
| Feb 20, 2020 | Citigroup | Maintained | — | Neutral |
| Jan 7, 2020 | BMO Capital | Upgrade | Market Perform | Outperform |
| Dec 18, 2019 | JP Morgan | Upgrade | Neutral | Overweight |
| Nov 26, 2019 | Stifel Nicolaus | Upgrade | Hold | Buy |
| Sep 12, 2019 | Berenberg | Initiated | — | Buy |
| Jun 20, 2019 | Citigroup | Initiated | — | Neutral |
| Jan 9, 2019 | BMO Capital | Downgrade | Outperform | Market Perform |
| Dec 13, 2018 | Jefferies | Downgrade | Buy | Hold |
| Nov 13, 2018 | Mizuho | Upgrade | Neutral | Buy |
| Oct 29, 2018 | SunTrust Robinson Humphrey | Maintained | Buy | Buy |
| Aug 29, 2018 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 16, 2018 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jul 10, 2018 | Mitsubishi UFJ | Downgrade | Overweight | Neutral |
